论文部分内容阅读
目的:对老年肺炎支原体感染患者采用阿奇霉素来进行治疗的效果以及安全性进行分析。方法:选取2011年10月-2013年10月荆门市中医医院收治的90例肺炎支原体感染老年患者,将其分成两组,每组各45例,对照组给予乳糖酸红霉素治疗,观察组给予阿奇霉素治疗,比较两组患者的疗效。结果:观察组的总有效率、不良反应发生率明显优于对照组,组间比较,差异均有统计学意义(P<0.05)。结论:在对肺支原体感染患者进行治疗时,阿奇霉素的效果较好,且在治疗过程中的不良反应相对较少。
Objective: To analyze the effect and safety of azithromycin in elderly patients with Mycoplasma pneumoniae infection. Methods: Ninety elderly Mycoplasma pneumoniae patients who were admitted to Jingmen Chinese Medicine Hospital from October 2011 to October 2013 were selected and divided into two groups, 45 cases in each group. The control group was treated with erythromycin lactobionate. The observation group Give azithromycin treatment, compared the efficacy of two groups of patients. Results: The total effective rate and the incidence of adverse reactions in the observation group were significantly better than those in the control group. The differences between the two groups were statistically significant (P <0.05). CONCLUSIONS: Azithromycin works well for patients with mycoplasma pneumoniae infections and has relatively few adverse reactions during treatment.